Point72 Asset Management
SNY icon

Point72 Asset Management’s Sanofi SNY Stock Holding History

Point72 Asset Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115,000
Closed -$6.38M – 2584
2025
Q1 		$6.38M Buy
+115,000
New +$6.22M 0.01% 840

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management's SNY Position: Q1 2026 in Review

Point72 Asset Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 331,765 shares — an estimated $16.1M sold.

Point72 Asset Management first reported a position in SNY in Q4 2014 and held it in 27 quarters. The position peaked at $121M in Q3 2021. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Point72 Asset Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 331,765 Sanofi shares in Q1 2026, an estimated $16.1M.
  • Point72 Asset Management first reported a position in Sanofi in Q4 2014 and held it in 27 quarters.
  • Point72 Asset Management's Sanofi position peaked at $121M in Q3 2021.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.